CDVA.CN stock down 42.86% to C$0.02 on CNQ, Canada: liquidity watch
CDVA.CN stock plunged 42.86% to C$0.02 in market hours on 30 Jan 2026, making it one of today’s top losers on the CNQ exchange in Canada. Volume was light at 9,000, against an average of 24,168, and market cap sits at C$2,346,344.00. The move follows weak liquidity signals and persistent losses in the cannabis retail and specialty drug space. We use Meyka AI’s market tools to frame the valuation, technicals and near-term catalysts for CordovaCann Corp. (CDVA.CN) ahead of an earnings date on 2026-03-04.
CDVA.CN stock: today’s plunge and market reaction
CordovaCann Corp. (CDVA.CN) lost 42.86% to C$0.02 after opening at C$0.02 and trading in a narrow intraday range of C$0.02–C$0.02. One-day loss equals a C$0.015 drop from the previous close of C$0.035. The sharp decline amplified year-to-date weakness of -42.86% and leaves the share well below the 50-day average of C$0.04 and the 200-day average of C$0.05.
Financial snapshot and valuation for CDVA.CN stock
CordovaCann shows negative earnings per share at EPS -C$0.01 and a trailing PE of -2.00, reflecting losses. Price-to-sales is low at 0.17 and enterprise value to sales is 0.50, but shareholders equity per share is negative at -C$0.05. Current ratio is weak at 0.19, and free cash flow per share is C$0.01, underscoring capital strain at the current market cap of C$2,346,344.00.
Technicals, liquidity and trading signals
Technical indicators show neutral momentum with RSI 50.51 and ADX 16.94 indicating no clear trend. On-chain trading data shows low liquidity: volume 9,000 versus average volume 24,168, and relative volume 0.37. Money flow is challenged with MFI 3.58, while OBV remains negative, pointing to distribution pressure and heightened short-term volatility.
Meyka AI rates CDVA.CN with a score out of 100
Meyka AI rates CDVA.CN with a score out of 100: 64.86 (Grade B, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, industry metrics, financial growth, key ratios, forecasts, and analyst consensus. The score balances low valuation metrics and model forecasts against weak liquidity and negative equity. These grades are model outputs and not investment advice.
Forecasts, price targets and risk outlook for CDVA.CN stock
Meyka AI’s forecast model projects C$0.04 monthly and C$0.06 quarterly targets, implying upside of 100.00% and 200.00% from the current C$0.02 price. A conservative scenario targets C$0.04 while an optimistic recovery target is C$0.06. Downside risk remains to C$0.01 if liquidity tightens or earnings disappoint. Forecasts are model-based projections and not guarantees.
Catalysts, sector context and upcoming events
CordovaCann operates in the Healthcare sector and Drug Manufacturers – Specialty & Generic industry, where sector performance has been mixed year-to-date. Key catalysts include the earnings announcement on 2026-03-04, possible store-level updates for the Star Buds Cannabis Co. brand, and any financing moves. Watch peer comparatives and regional retail trends for signs of operational improvement. Recent comparative commentary appears on investing.com source and source.
Final Thoughts
CDVA.CN stock’s 42.86% drop to C$0.02 on CNQ highlights acute liquidity stress and continued valuation pressure for CordovaCann Corp. Key ratios show negative equity per share (-C$0.05) and a thin current ratio (0.19), while EPS sits at -C$0.01. Meyka AI’s forecast model projects C$0.04 monthly and C$0.06 quarterly, implying upside of 100.00% and 200.00% versus today’s price, but those gains depend on improved trading liquidity and a clean earnings release on 2026-03-04. Traders should weigh the stock’s low market cap (C$2,346,344.00) and thin volume (9,000) against the model targets. For longer-term investors, recovery hinges on operational improvements and capital stability. Meyka AI’s tools provide a data-driven frame for monitoring CDVA.CN stock, yet forecasts are model-based projections and not guarantees. Conduct further due diligence before acting.
FAQs
Why did CDVA.CN stock drop 42.86% today?
The plunge to C$0.02 reflects thin liquidity, weak average volume of 24,168, negative equity per share, and market reaction ahead of the 2026-03-04 earnings announcement.
What is Meyka AI’s forecast for CDVA.CN stock?
Meyka AI’s forecast model projects C$0.04 monthly and C$0.06 quarterly targets. These imply 100.00% and 200.00% upside from C$0.02, and are model projections, not guarantees.
What valuation metrics should investors watch for CDVA.CN stock?
Key metrics include EPS -C$0.01, PE -2.00, price-to-sales 0.17, enterprise value to sales 0.50, and current ratio 0.19 to monitor solvency and valuation trends.
Is CordovaCann (CDVA.CN) a buy after the drop?
Meyka AI assigns a B (64.86) grade with a HOLD suggestion. Potential upside exists, but risks include low liquidity, negative equity, and near-term earnings. Perform your own research.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
